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Abstract
Background: The aim of this study was to investigate the clinical patterns in young Chinese patients (less than
40 years old) with laryngeal squamous cell cancer (LSCC) and the outcome of primary open surgery.
Methods: Thirty-four young patients, with histologically confirmed LSCC between 1985 and 2005 at Qilu Hospital
and Affiliated Hospital of Weifang Medical College, who underwent primary open surgery were retrospectively evaluated
according to the clinical patterns in comparison with 374 non-young patients (older than 40 years). The Kaplan-Meier
method was used to calculate the survival rate. The relevance of smoking, tumor location, tumor-node-metastasis (TNM)
staging, lymph node involvement, tumor size, and histological differentiation to overall survival was tested by
multivariate analysis.
Results: There was a significantly higher rate of smoking (p = 0.020) in the non-young patients compared to the young
patients, but no significant difference was observed in alcohol consumption, tumor location, tumor size, TNM staging,
lymph node metastasis, histological grade, and 5-year overall survival.
One-year survival rates were 100 %, 3-year survival rates were 79.41 %, and 5-year survival rates were 67.65 %. In the
multivariate analysis, lymph node involvement (p = 0.006), tumor stage (p = 0.022), and tumor size (p = 0.004) proved to
be significant predictors of overall survival.
Conclusions: The incidence of smoking was significantly higher in non-young patients compared to young patients.
Primary surgery with or without radiotherapy may provide a value treatment option for young LSCC. Nodal status, tumor
stage, and tumor size were the primary determinants of overall survival in multivariate analysis. These data may provide
useful information for counseling and treatment planning.
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Background
Laryngeal carcinoma, which originates from a subsite of
the upper respiratory tract, was diagnosed in 20,875
men and women in China in 2011 [1], and laryngeal
squamous cell carcinoma (LSCC) is by far the most fre-
quent histology. As this type of cancer impairs the func-
tions of breathing, swallowing, and speech, treatment
decisions for this disease are dependent in large part on
assessment of disease extent and performance status
with the aim of high-survival rates and excellent organ
function preservation. Great developments in manage-
ment of laryngeal carcinoma have been seen over the
past century. Surgery, radiotherapy, and chemotherapy
alone or in combination are the main treatments for this
disease.
The standard of management for laryngeal carcinoma
still remains controversial. It is hard to justify, from the
literature, which choice of therapy is the best. Partial lar-
yngectomy, laser resection, or radiation therapy alone is
utilized for early laryngeal tumors, while subtotal laryn-
gectomy or total laryngectomy followed by radiotherapy
is adopted for advanced laryngeal malignancies [2].
However, the Department of Veterans Affairs Laryngeal
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Cancer Study Group offered the potential value of in-
duction chemotherapy plus radiation in achieving laryn-
geal preservation with survival rates comparable to
surgery as the primary treatment for advanced laryngeal
cancer [3]. Of note, a recent study indicated that laryn-
geal carcinoma survival has decreased among patients
with laryngeal cancer during the past two decades in the
USA [4]. More recently, several findings involving the
therapeutic use of surgery showed that this treatment
might be a better therapy for better survival outcomes
than nonsurgical therapy for patients with advanced
laryngeal cancer [5, 6]. Although there is no difference
in choice of treatment between the young and non-
young patients with LSCC, the experience of manage-
ments of these young patients with LSCC is so limited
in that young patients less than 40 years old are rela-
tively rare [7, 8].
To date, few reports have been available focusing on
clinical characteristics of young LSCC and the efficacy of
open surgery as the initial treatment for them. With
these points in mind, our aim was to investigate the
clinical characteristics of young patients with LSCC
compared with older counterparts and to evaluate the
value of open surgery. Moreover, we further explored
the prognostic factors that had a significant impact
on 5-year overall survival rates.
Methods
A total of 34 young Chinese patients with LSCC (less
than 40 years) who underwent partial, subtotal, or total
laryngectomy as the initial treatment in Qilu Hospital
and the Affiliated Hospital of Weifang Medical College
between the years 1985 and 2005 were enrolled in our
study. Another 374 LSCC patients aged over 40 years
were randomly selected as a comparison cohort. The
patterns of clinicopathological and 5-year survival rates
after treatments were compared between the two
groups.
Those patients with distant metastases or with histo-
logical findings other than squamous cell carcinoma at
the time of diagnosis were excluded from the study.
None of these patients had received preoperative radio-
therapy or adjuvant therapy, and none were treated by
transoral laser surgery. High-resolution computed tomo-
graphic (CT) scanning of the primary tumor was per-
formed to ascertain extent of the tumors.
The diagnoses were confirmed by a combination of
laryngoscopic examination and preoperative pathological
examination. The histological specimens in each case
were examined by two competent pathologists without
knowledge of the patients’ clinicopathological character-
istics and clinical outcome. Discrepancies were resolved
by two advanced pathologists who reviewed the immu-
nostained slides together under a multi-head microscope
until a consensus was reached. Furthermore, the histo-
logical subtypes were determined by analyzing the speci-
men slides. Clinical stages were determined according to
the tumor-node-metastasis (TNM) classification system
of the International Union [9].
After successful resection of the tumor with an electric
knife, the specimens were sent for final histopathological
evaluation. Moreover, the surgical margin specimens are
rapidly submitted to a pathologist for careful frozen
histopathological section examination. If positive, add-
itional tissue was removed until the margins were clear
in order to reduce postoperative recurrence of the
carcinoma.
Selective neck dissection was performed for N0 neck
with supraglottic cancers. Bilateral modified neck dissec-
tion is commonly performed for cases with clinically evi-
dent neck nodal metastases.
Postoperative anti-inflammatory drugs and dressing
changes each day were utilized for about 8 days. Nutri-
tional support was applied due to abrosia, and the aver-
age period of time before the nasogastric tube was
removed was 10.33 days. Postoperative radiotherapy was
carried out 5 weeks after the operation when necessary.
The mean time of hospital stay was 15.36 days.
The patients were followed up every 3 months in the
first year after operation, every 6 months in the second
year, and every 2 years after the operation. The follow-
up ended in April 2013. The overall survival was defined
as the internal between the date of surgery and the date
of death. The median follow-up period after surgery was
62.52 months (range 13–120 months).
Statistic analysis
The chi-square test was used to analyze the correlation
between clinicopathological characteristics of the two
groups. Kaplan-Meier survival curves were employed to
evaluate the 5-year overall survival. The log-rank test
was used to draw survival curves. A multivariate Cox re-
gression model was adopted to evaluate the independent
effect of clinicopathological features diagnosis on sur-
vival from the younger patients with LSCC. All statistical
tests were two-sided, and p values less than 0.05 were
considered to be statistically significant. All analyses
were conducted using SPSS version 16.0 statistical
software
Results
The total of 34 patients that satisfied the inclusion cri-
teria were analyzed as the younger age group. Among
these, the mean age was 34.6 2 years and the range was
from 24 to 39 years. A detailed description of age is pre-
sented in Table 1. All 34 patients were male. When clas-
sified according to anatomic location, 11 cases (32.35 %)
had supraglottic carcinoma, 22 cases (64.71 %) had
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glottic carcinomas, and one case (2.94 %) had infraglot-
tic carcinoma. According to pathology, 24 cases
(70.59 %) were classified as well and moderate differenti-
ated and ten cases (29.41 %) as poorly differentiated. For
younger patients, the most common operation was verti-
cal partial laryngectomy with 21 surgeries (61.76 %),
followed by eight horizontal glottis surgeries (23.53 %),
four (11.76 %) total laryngectomy, and one (2.94 %) sub-
total laryngectomy. Two patients, one with positive and
one with close surgical margins underwent surgical re-
excision. Fourteen patients (41.18 %) also had a nodal
operation. Postoperative radiotherapy was recommended
to optimize regional control for 15 (44.12 %) patients.
The functional larynx was successfully preserved in 29
(85.29 %) of the younger patients. Decannulation was
performed in 28 (82.35 %) younger patients. As for post-
operative complication, one patient experienced infec-
tion and no patients died. For the younger population,
1-year survival was 100 % in this series, 3-year survival
was 79.41 %, and 5-year survival was 67.65 %, as shown
in Fig. 1.
With regard to the 374 patients diagnosed with LSCC
(older than 40 years), their mean age was 58.61 years
ranging from 40 to 85 years. Of these patients, 329
(87.97 %) were male and 45 (12.03 %) were female.
When classified according to anatomic location, 82 cases
(21.93 %) had supraglottic carcinomas, 278 cases
(74.33 %) had glottic carcinomas, and 14 cases (3.74 %)
had subglottic carcinomas. According to pathology, 301
cases (64.97 %) were classified as well differentiated and
moderate, and 73 cases (33.96 %) as poorly differenti-
ated. The clinical stage distribution according to age
group was as follows: stage I and stage II, 21 (61.76 %)
patients in the younger age group and 247 (66.04 %) in
the older age group, while 13 (38.24 %) cases were found
in stage III and stage IV in the younger age group and
127 (33.96 %) cases in the older age group. For the older
LSCC patients, 1-year survival, 3-year survival, 5-year
survival were 100, 75.68, and 66.31 %, respectively. A de-
tailed description of sex, tumor localization, N status,
histological differentiation, and other demographics is
presented in Table 2. There was a significantly higher
rate of smoking (p = 0.020) in the non-young patients
compared to the young ones, but no significant
Table 1 Presentation of age in cases of young patients







Fig. 1 A Kaplan-Meier analysis of the overall survival of young patients
with LSSC
Table 2 Clinicopathological variables between the less than
40 years group and the more than 40 years group
Variables No. of patients p
Age (years) <40 ≥40
Alcohol consumption
Current or former 20 (58.82 %) 260 (69.52 %) 0.198
Never 14 (41.18 %) 114 (30.48 %)
Smoking
Current or former 20 (58.82 %) 287 (76.74 %) 0.020
Never 14 (41.18 %) 87 (23.26 %)
Tumor location
Larynx glottic 22 (64.71 %) 278 (74.33 %) 0.223
Larynx non-glottic 12 (35.29 %) 96 (25.67 %)
Histological differentiation
Well and moderate 24 (70.59 %) 301 (80.48 %) 0.170
Poor 10 (29.41 %) 73 (19.52 %)
Tumor size
Less than 3 cm 25 (73.53 %) 276 (73.80 %) 0.973
More than 3 cm 9 (26.47 %) 98 (26.20 %)
Node involvement
Yes 6 (17.65 %) 76 (20.32 %) 0.710
No 28 (82.35 %) 298 (79.68 %)
Stage
I + II 21 (61.76 %) 247 (66.04 %) 0.615
III + V 13 (38.24 %) 127 (33.96 %)
5-year survival
Alive 23 (67.65 %) 248 (66.31 %) 0.874
Dead 11 (32.35 %) 126 (33.69 %)
p value is the result of chi-square test in the same factor, and p< 0.05 is considered
statistically significant
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difference was observed in alcohol consumption, tumor
location, tumor size, TNM staging, lymph node metasta-
sis, histological grade, and 5-year overall survival.
Multivariate analysis was used to analyze prognostic
factors of 5-year overall survival (OS) for patients. As
depicted in Table 3, some variables were stratified to
assess the different effects on OS. In addition to
lymph node status (p = 0.006), TNM stage (p = 0.022)
and tumor size (p = 0.004) were independent prognos-
tic factors for poorer OS in multivariate analysis.
However, no statistically significant correlation between
smoking (p = 0.602), differentiation status (p = 0.154),
tumor location (p = 0.324), and overall survival was found
among the young patients with LSCC.
Discussion
The study data consisted of cancer patients over a long
term from 1985 to 2005 and in a wide area including
large rural areas and urban areas. As such, this report
represents a view of the successful management of youn-
ger patients with laryngeal SCC.
The incidence of head and neck cancer differed in
various regions. A previous report showed that the inci-
dence of head and neck cancer was increasing in women
[10]. Also, the incidence of women appeared to increase
in The Netherlands while the male to female ratio of this
disease has declined [11]. For the total of Chinese pa-
tients, the male to female ratio of laryngeal carcinoma is
commonly about 6–7:1, but it is about 1.97:1 in the
northeast of China, maybe partly due to more female
smokers in this region [2]. In the present study, there
were no female laryngeal cancer patients in the younger
cohort.
With regard to the development of laryngeal carcin-
oma, it is a complex process that involves multiple steps.
Of the factors affecting the progress of laryngeal cancer,
smoking may play a significant role in the progress. In
this present investigation, 58.82 % of young patients had
a history of heavy smoking. The rate of smoking was sig-
nificantly higher in non-young patients compared to
young patients, which is in agreement with a previous
study [12].
Cancer of the larynx is divided anatomically into glot-
tis carcinoma, supraglottic carcinoma, and subglottic
carcinoma. In the present study, over one third of the
younger patients had primary supraglottic squamous cell
carcinoma, and nearly two thirds of the younger patients
had primary glottic squamous cell carcinoma. Patients
with glottic squamous cell carcinoma are usually diag-
nosed in an early stage and have an excellent prognosis.
Optimal treatment for LSCC has not been established,
and treatment options have been dependent on the insti-
tution’s policy. Our preference has been to use open par-
tial laryngectomy for the majority of the patients. The
surgeon should consider the patient’s prognosis with the
preservation of postoperative function. Also, the surgery
of laryngeal cancer should be individualized according to
the size and extent of the tumor, the age, and physical
condition of the patient, and the skill and experience of
the surgeon with various treatment modalities and surgi-
cal procedures [13].
Open partial laryngectomy which is important in the
management of patients with early LSCC has already
been characterized. First, it is believed that open partial
laryngectomy preserves the organ function to increase
the quality of life. Second, in contrast to radiotherapy,
open surgery can be repeated for curative purposes,
whereas postoperative radiation therapy in patients with
positive margins did not improve survival [14].
Third, patients with T2 tumors may have a better local
control rate after open partial laryngectomy compared
to laser resection and radiotherapy [15].
In the young cohort, we had a high number of open
partial laryngectomy (29 patients or 85.29 %), with good
functional larynx preservation (30 patients or 88.24 %)
and high decannulation which improved the quality of
life. The 5-year survival rate was 67.65 %, which is simi-
lar to a previous study [4].
The major prognostic factors for head and neck cancer
are the presence of lymphatic involvement, positive
surgical margins, locoregional metastasis, T stage, and
extracapsular spread of tumor cells from involved nodes
into the soft tissue of the neck [16, 17]. Another study
showed that young age may confer a worse prognosis in
patients with squamous cell carcinoma of larynx [5]. In
Table 3 Multivariate analysis of 5-year survival in young Chinese LSCC patients after surgery
Factors B SE Wald Sig Exp (B) (95 % CI)
Smoking (current or former/never) 1.788 1.171 2.331 0.127 5.976 (0.602–59.298)
Histologic grade (non-poor/poor) −0.390 0.755 0.266 0.606 0.677 (0.154–2.976)
Tumor location (larynx, glottic/larynx, nonglottic) 0.528 0.844 0.390 0.532 1.695 (0.324–8.868)
The largest size (≤3 cm/>3 cm) −3.350 1.152 8.460 0.004 0.035 (0.004–0.335)
TNM stage (I + II/III + IV) −2.442 1.066 5.245 0.022 0.087 (0.011–0.703)
Lymph node metastasis (absent/present) −3.148 1.150 7.492 0.006 0.043 (0.005–0.409)
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the present study, our analysis identified that nodal sta-
tus, tumor stage, and tumor size adversely impacted 5-
year overall survival.
The strengths of the study were that it featured ad-
equate follow-up, a comparison with a large cohort, and
face-to-face conversation with patients or their relatives
to obtain detailed information. However, future surveys
with larger study cohorts are warranted to further verify
our results.
Conclusions
To conclude, the findings presented here are the first to
investigate the clinical patterns in young Chinese pa-
tients with LSCC and their outcome of open surgery.
This study has shown that the incidence of smoking was
significantly higher in non-young patients compared to
young patients and that open surgical treatment as the
initial treatment was effective for the young cohorts. In
addition, nodal status, tumor stage, and tumor size were
the primary determinants of 5-year overall survival.
These data may provide useful information for counsel-
ing and treatment planning for anti-laryngeal cancer
therapy.
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